您的位置: 首页 > 农业专利 > 详情页

Express TH1 cell characteristics and cytolytic matter
专利权人:
이뮤노베이티브 테라피스, 엘티디.
发明人:
하-노이, 마이클
申请号:
KR1020137004186
公开号:
KR1019008070000B1
申请日:
2011.08.22
申请国别(地区):
KR
年份:
2018
代理人:
摘要:
A kind of novel cell type generates that and has both Th1 characteristics and dissolved cell activity. It from peripheral blood and is operated to Th1 characteristics after these TH1/limiter unit CD4+ lymphocyte depletions, such as production IFN-gamma can be with the cytotoxic T-Lymphocyte (CTL) that is similar to dissolved cell activity. The CTL activity is using sick cell as target, not normal cell. TH1/killer cell line B-Perforin mechanisms of dissolved cell activity are dead by Telomerase mediated apoptosis and led to the cell of illness. It includes isolation CD4+ cells from peripheral blood that method, which produces and use these TH1/limiter units, and to form TH1/limiter cell, to patient, wherein TH1/killer cell line patient is allogeneic to T cell activation CD4+ with cell of these TH1/limiters with dissolved cell activity is applied.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充